Tag: <span>androgen deprivation therapy</span>

Home / androgen deprivation therapy
Metformin’s role in preventing metabolic syndrome during androgen deprivation therapy
Post

Metformin’s role in preventing metabolic syndrome during androgen deprivation therapy

by Impact Journals LLC Variable changes in phosphorylation of S6 kinase 1 was observed in both cohorts. Credit: Oncotarget (2023). DOI: 10.18632/oncotarget.28458 A new research paper titled “Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer” has been published in Oncotarget ....

Post

Osteoporosis medications improve bone health in men with prostate cancer receiving androgen deprivation therapy

Both biophosphonates and denosumab improve bone mineral density (BMD) in men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT). The results from a systematic review and meta-analysis are published in Annals of Internal Medicine. One in two men with prostate cancer receives ADT at some point after diagnosis. While ADT has been the mainstay of...